• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

眼黑色素瘤——当你见过一个,并不意味着你见过了所有:一项来自监测、流行病学和最终结果(SEER)数据库(1973 - 2012年)的临床结局研究

Ocular melanoma-when you have seen one, you have not seen them all: a clinical outcome study from the Surveillance, Epidemiology and End Results (SEER) database (1973-2012).

作者信息

Mahendraraj Krishnaraj, Shrestha Sneha, Lau Christine Sm, Chamberlain Ronald S

机构信息

Department of Surgery, Saint Barnabas Medical Center, Livingston, NJ, USA.

Department of Surgery, Saint Barnabas Medical Center, Livingston, NJ, USA; Saint George's University School of Medicine, Grenada, West Indies.

出版信息

Clin Ophthalmol. 2017 Jan 5;11:153-160. doi: 10.2147/OPTH.S120530. eCollection 2017.

DOI:10.2147/OPTH.S120530
PMID:28115829
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5221652/
Abstract

BACKGROUND

Ocular melanoma (OM) comprises <5% of all melanomas. Uveal melanoma (UM) is the most common subtype of OM, while conjunctival melanoma (CM) is rare and differs significantly from UM. The purpose of this study is to evaluate a large cohort of OM patients to differentiate demographic, pathologic, and clinical factors between these two neoplasms, which may affect treatment and outcomes.

METHODS

The Surveillance, Epidemiology, and End Results database (1973-2012) was used to extract demographic and clinical data on 8,165 OM patients (92.1% UM and 7.9% CM).

RESULTS

Both CM and UM were most prevalent among Caucasian males in the seventh decade of life. UM patients presented more often with localized disease (90.9% vs 81.2, <0.01). Surgery (42.8%), radiation (43.0%), or combined surgery and radiation (7.0%) were used in the treatment of UM, while CM was treated almost exclusively with surgery (88.7%). Mean overall survival was longer (15.4 vs 14.6 years; <0.01) and mortality rates were lower in patients (38.8% vs 46.1%; <0.01) with CM.

CONCLUSION

Despite presenting with more advanced disease than UM, CM is associated with an increased overall survival. Surgery is the primary therapy for CM, whereas radiotherapy is the primary therapy for UM and is associated with prolonged survival.

摘要

背景

眼黑色素瘤(OM)占所有黑色素瘤的比例不到5%。葡萄膜黑色素瘤(UM)是OM最常见的亚型,而结膜黑色素瘤(CM)较为罕见,且与UM有显著差异。本研究的目的是评估一大群OM患者,以区分这两种肿瘤之间的人口统计学、病理学和临床因素,这些因素可能会影响治疗和预后。

方法

利用监测、流行病学和最终结果数据库(1973 - 2012年)提取8165例OM患者(92.1%为UM,7.9%为CM)的人口统计学和临床数据。

结果

CM和UM在70岁的白种男性中最为常见。UM患者更多表现为局限性疾病(90.9%对81.2%,<0.01)。UM的治疗采用手术(42.8%)、放疗(43.0%)或手术联合放疗(7.0%),而CM几乎仅采用手术治疗(88.7%)。CM患者的平均总生存期更长(15.4年对14.6年;<0.01),死亡率更低(38.8%对46.1%;<0.01)。

结论

尽管CM比UM表现出更晚期的疾病,但CM与总生存期增加相关。手术是CM的主要治疗方法,而放疗是UM的主要治疗方法且与生存期延长相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abc0/5221652/fa9524cda99b/opth-11-153Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abc0/5221652/5d7aced367a9/opth-11-153Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abc0/5221652/fa9524cda99b/opth-11-153Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abc0/5221652/5d7aced367a9/opth-11-153Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/abc0/5221652/fa9524cda99b/opth-11-153Fig2.jpg

相似文献

1
Ocular melanoma-when you have seen one, you have not seen them all: a clinical outcome study from the Surveillance, Epidemiology and End Results (SEER) database (1973-2012).眼黑色素瘤——当你见过一个,并不意味着你见过了所有:一项来自监测、流行病学和最终结果(SEER)数据库(1973 - 2012年)的临床结局研究
Clin Ophthalmol. 2017 Jan 5;11:153-160. doi: 10.2147/OPTH.S120530. eCollection 2017.
2
Trends in incidence, survival, and management of uveal melanoma: a population-based study of 7,516 patients from the Surveillance, Epidemiology, and End Results database (1973-2012).葡萄膜黑色素瘤的发病率、生存率及治疗趋势:一项基于监测、流行病学和最终结果数据库(1973 - 2012年)中7516例患者的人群研究。
Clin Ophthalmol. 2016 Oct 25;10:2113-2119. doi: 10.2147/OPTH.S113623. eCollection 2016.
3
Uveal and conjunctival melanomas: disease course and outcomes in Chinese patients.葡萄膜和结膜黑色素瘤:中国患者的疾病进程和结局。
Hong Kong Med J. 2023 Dec;29(6):506-513. doi: 10.12809/hkmj219451. Epub 2023 Dec 4.
4
Epidemiology and survival outcomes of ocular and mucosal melanomas: a population-based analysis.眼部和黏膜黑色素瘤的流行病学和生存结果:基于人群的分析。
Int J Cancer. 2014 Jun 15;134(12):2961-71. doi: 10.1002/ijc.28625. Epub 2013 Dec 2.
5
Comparing the Hem- and Lymphangiogenic Profile of Conjunctival and Uveal Melanoma Cell Lines.比较结膜和葡萄膜黑色素瘤细胞系的血管生成和淋巴管生成特征。
Invest Ophthalmol Vis Sci. 2015 Aug;56(9):5691-7. doi: 10.1167/iovs.15-16829.
6
Surgery vs. radiotherapy in patients with uveal melanoma : Analysis of the SEER database using propensity score matching and weighting.葡萄膜黑色素瘤患者手术与放疗的比较:使用倾向评分匹配和加权对监测、流行病学和最终结果(SEER)数据库进行分析
Strahlenther Onkol. 2017 Nov;193(11):931-942. doi: 10.1007/s00066-017-1203-0. Epub 2017 Sep 6.
7
Primary bilateral uveal melanoma: a population-based study and systematic review.原发性双侧葡萄膜黑色素瘤:基于人群的研究和系统评价。
Clin Exp Ophthalmol. 2018 Jul;46(5):502-510. doi: 10.1111/ceo.13129. Epub 2018 Jan 10.
8
Mortality after uveal and conjunctival melanoma: which tumour is more deadly?葡萄膜和结膜黑色素瘤后的死亡率:哪种肿瘤更致命?
Acta Ophthalmol. 2009 Mar;87(2):149-53. doi: 10.1111/j.1755-3768.2008.01369.x. Epub 2008 Oct 15.
9
Ocular melanoma and the BAP1 hereditary cancer syndrome: implications for the dermatologist.眼黑色素瘤与BAP1遗传性癌症综合征:对皮肤科医生的启示
Int J Dermatol. 2014 Jun;53(6):657-63. doi: 10.1111/ijd.12386. Epub 2014 Apr 2.
10
So Close, yet so Far: Discrepancies between Uveal and Other Melanomas. A Position Paper from UM Cure 2020.如此相近,却又如此不同:葡萄膜黑色素瘤与其他黑色素瘤之间的差异。UM Cure 2020立场文件
Cancers (Basel). 2019 Jul 22;11(7):1032. doi: 10.3390/cancers11071032.

引用本文的文献

1
A Population-Based Study of Sex Differences in Cardiovascular Disease Mortality Among Adults with Ocular Cancer in the United States, 2000-2021.2000 - 2021年美国眼癌成年患者心血管疾病死亡率性别差异的基于人群的研究。
Curr Oncol. 2025 Aug 8;32(8):447. doi: 10.3390/curroncol32080447.
2
The surgical effect and safety of a novel intraocular choroidal melanoma resection.一种新型眼内脉络膜黑色素瘤切除术的手术效果及安全性
Front Med (Lausanne). 2025 May 30;12:1554581. doi: 10.3389/fmed.2025.1554581. eCollection 2025.
3
Genetic landscape of uveal melanoma in Southeast Asia: high 1q gains and unique patterns of metastasis risk.

本文引用的文献

1
Disparities in Uveal Melanoma: Patient Characteristics.葡萄膜黑色素瘤的差异:患者特征
Semin Ophthalmol. 2016;31(4):296-303. doi: 10.3109/08820538.2016.1154176. Epub 2016 Apr 29.
2
Orchestrating epigenetic roles targeting ocular tumors.调控针对眼部肿瘤的表观遗传作用。
Onco Targets Ther. 2016 Feb 29;9:1001-9. doi: 10.2147/OTT.S93995. eCollection 2016.
3
Class III-specific HDAC inhibitor Tenovin-6 induces apoptosis, suppresses migration and eliminates cancer stem cells in uveal melanoma.III类特异性组蛋白去乙酰化酶抑制剂Tenovin-6可诱导葡萄膜黑色素瘤细胞凋亡、抑制其迁移并消除癌症干细胞。
东南亚葡萄膜黑色素瘤的基因图谱:1q高增益及转移风险的独特模式
Eye Vis (Lond). 2025 Apr 16;12(1):15. doi: 10.1186/s40662-025-00430-8.
4
Brachytherapy in the prevention of recurrence of conjunctival melanoma : Results of a case report in a University Hospital in Valladolid, Spain.西班牙巴利亚多利德大学医院的病例报告:近距离放射治疗预防结膜黑色素瘤复发的结果。
Strahlenther Onkol. 2023 Nov;199(11):1025-1030. doi: 10.1007/s00066-023-02094-6. Epub 2023 Jun 6.
5
Concomitant uveal melanoma and papillary thyroid carcinoma: a case report.葡萄膜黑色素瘤和甲状腺乳头状癌并存:一例报告。
J Med Case Rep. 2022 Jan 18;16(1):29. doi: 10.1186/s13256-022-03258-1.
6
Uveal Melanoma Identified as Ocular Mass on Point-of-care Ultrasound.葡萄膜黑色素瘤在床旁超声检查中被识别为眼部肿物。
Clin Pract Cases Emerg Med. 2021 Aug;5(3):367-368. doi: 10.5811/cpcem.2021.4.52115.
7
Genetics of Ocular Melanoma: Insights into Genetics, Inheritance and Testing.眼黑素瘤的遗传学:遗传学、遗传与检测的新视角。
Int J Mol Sci. 2020 Dec 30;22(1):336. doi: 10.3390/ijms22010336.
8
Impact of Marital Status on Survival in Patients with Ocular and Periocular Malignancies: A Retrospective Analysis of 3159 Patients from the SEER Database.婚姻状况对眼及眼周恶性肿瘤患者生存的影响:对监测、流行病学与最终结果(SEER)数据库中3159例患者的回顾性分析
Clin Ophthalmol. 2020 Apr 23;14:1127-1133. doi: 10.2147/OPTH.S238034. eCollection 2020.
9
Incidence and Survival of Patients With Conjunctival Melanoma in Europe.欧洲结膜黑色素瘤患者的发病率和生存率。
JAMA Ophthalmol. 2020 Jun 1;138(6):601-608. doi: 10.1001/jamaophthalmol.2020.0531.
10
Prognostic Factors Five Years After Enucleation for Uveal Melanoma.葡萄膜黑色素瘤眼球摘除术后 5 年的预后因素。
Invest Ophthalmol Vis Sci. 2020 Mar 9;61(3):31. doi: 10.1167/iovs.61.3.31.
Sci Rep. 2016 Mar 4;6:22622. doi: 10.1038/srep22622.
4
Brachytherapy vs. external beam radiotherapy for choroidal melanoma: Survival and patterns-of-care analyses.近距离放射治疗与外照射放疗治疗脉络膜黑色素瘤的生存及治疗模式分析
Brachytherapy. 2016 Mar-Apr;15(2):216-23. doi: 10.1016/j.brachy.2015.12.001. Epub 2016 Feb 1.
5
Clinical Management of Uveal and Conjunctival Melanoma.葡萄膜和结膜黑色素瘤的临床管理
Oncology (Williston Park). 2016 Jan;30(1):29-32, 34-43, 48.
6
Role of Genetics and Epigenetics in Mucosal, Uveal, and Cutaneous Melanomagenesis.遗传学和表观遗传学在黏膜、葡萄膜及皮肤黑色素瘤发生中的作用
Anticancer Agents Med Chem. 2016;16(5):528-38. doi: 10.2174/1871520615666150803124139.
7
The Mayo Clinic experience with the use of kinase inhibitors, ipilimumab, bevacizumab, and local therapies in the treatment of metastatic uveal melanoma.梅奥诊所使用激酶抑制剂、伊匹木单抗、贝伐单抗及局部治疗方法治疗转移性葡萄膜黑色素瘤的经验。
Melanoma Res. 2015 Feb;25(1):59-63. doi: 10.1097/CMR.0000000000000125.
8
The demethylating agent 5-Aza reduces the growth, invasiveness, and clonogenicity of uveal and cutaneous melanoma.去甲基化剂5-氮杂胞苷可降低葡萄膜黑色素瘤和皮肤黑色素瘤的生长、侵袭性及克隆形成能力。
Invest Ophthalmol Vis Sci. 2014 Aug 21;55(10):6178-86. doi: 10.1167/iovs.14-13933.
9
A molecular revolution in uveal melanoma: implications for patient care and targeted therapy.葡萄膜黑色素瘤的分子革命:对患者护理和靶向治疗的影响。
Ophthalmology. 2014 Jun;121(6):1281-8. doi: 10.1016/j.ophtha.2013.12.014. Epub 2014 Jan 28.
10
Current and emerging treatment options for uveal melanoma.葡萄膜黑色素瘤的当前及新出现的治疗选择
Clin Ophthalmol. 2013;7:1669-82. doi: 10.2147/OPTH.S28863. Epub 2013 Aug 22.